Skip to main content
logo
MindMaze Therapeutics Holding SA (SWX:MMTX)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
0.1522
-0.0022 (-1.42%)
Oct 22, 2026, 5:30 PM CEST

SWX:MMTX Revenue

In the year 2024, MindMaze Therapeutics Holding had annual revenue of 8.42M CHF with 39.52% growth. That makes MindMaze Therapeutics Holding the 42,991st largest company in the world by revenue and 199th in Switzerland.

Revenue
8.42M
Revenue Growth
+39.52%
P/S Ratio
21.95
Revenue / Employee
n/a
Employees
n/a
Market Cap
25.87M

Revenue Chart

Chart

Revenue by Geography

Chart
  • Asia 255.00K 39.7%
  • USA 171.00K 26.6%
  • Europe (Excl. Switzerland) 137.00K 21.3%
  • Switzerland 60.00K 9.3%
  • Rest of The World 19.00K 3.0%
Fiscal year ended Dec 31, 2025 See the full SWX:MMTX breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20248.42M2.38M39.52%
Dec 31, 20236.03M-48.00K-0.79%
Dec 31, 20226.08M2.76M83.11%
Dec 31, 20213.32M--
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018565.00K--
Dec 31, 2017---
Dec 31, 201615.00K-242.23K-94.17%
Dec 31, 2015257.23K--
Dec 31, 2014---
Dec 31, 201320.74M-14.19M-40.62%
Dec 31, 201234.93M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Bachem Holding AG708.53M
Basilea Pharmaceutica AG247.42M
Idorsia199.71M
Santhera Pharmaceuticals Holding AG101.50M
Newron Pharmaceuticals9.62M
BioVersys AG4.62M
Molecular Partners AG681.00K
Xlife Sciences AG397.23K
Revenue Rankings

MindMaze Therapeutics Holding News

More News